Treatment
Medication clinical trials
We’re tracking 7,446 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07010094Recruiting
Shockwave balloons for hardened heart artery blockages
This trial tests a special balloon that uses shock waves to crack calcium in heart arteries, making it easier to place a stent. It is for people with chest pain or signs of heart strain due to a single, severely blocked artery with dense calcium.
Fujian, XiamenAges 18–85 - NCT07010341Recruiting
Dye test to check parathyroid blood flow during thyroid surgery
This trial tests a dye called indocyanine green (ICG) to see how well it shows blood flow to the tiny parathyroid glands during thyroid surgery. This may help doctors know right away if the glands are healthy, which could lower the chance of complications.
Fuzhou, FujianAges Any age - NCT07012798RecruitingPhase 2
Sequential therapy for advanced liver cancer that may become removable
This trial tests a sequence of chemotherapy (FOLFOX), immunotherapy (durvalumab), targeted therapy (bevacizumab), and focused radiation to shrink liver tumors that are not removable now, with the goal of making them operable later.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07012915Recruiting
Study of Immune Causes of Implant Inflammation
This trial studies severe inflammation around dental implants (peri-implantitis). It aims to understand the immune and tissue changes causing this condition, which may lead to new treatment approaches.
Wroclaw, Lower Silesian VoivodeshipAges 18 years+ - NCT07013565RecruitingPhase 2
Chemoimmunotherapy for ALK+ ALCL that has come back
This trial tests a combination of chemotherapy and immunotherapy for children and adults with a type of lymphoma called ALK-positive anaplastic large cell lymphoma that has returned or not responded to previous treatment. The goal is to see if this new approach can help control the disease.
Valhalla, New YorkAges 1–39 - NCT07014150RecruitingPhase 2
Neoadjuvant combo therapy for liver cancer before surgery
This trial tests a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) plus lenvatinib (a targeted therapy) given before surgery for hepatocellular carcinoma (a type of liver cancer). The goal is to see if this treatment can shrink tumors and reduce the chance of cancer coming back after surgery.
Beijing, Beijing MunicipalityAges 18–75 - NCT07014202RecruitingPhase 2
Radiation therapy after chemo-immunotherapy for lung cancer
This trial tests whether giving focused radiation to remaining spots of lung cancer (after standard treatment) can help prevent cancer from growing back. It may be an option if you have had 4-6 cycles of chemo plus immunotherapy and still have a few active spots.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07014501Recruiting
Stroke recovery and trach tube removal at different altitudes
This trial studies how well stroke patients with a breathing tube (tracheostomy) can have it removed. It looks at genes and blood oxygen levels, and compares patients at different altitudes to find the best timing for removal.
Kunming, YunnanAges 18–75 - NCT07014592Recruiting
Brain activity study in drug-resistant epilepsy patients
This study looks at brain activity in people with epilepsy that does not get better with medicine. Researchers want to record your brain's electrical responses during surgery for your seizures to learn more about how epilepsy works.
Ann Arbor, MichiganAges 22–75 - NCT07016854Recruiting
Early treatment for blocked carotid artery stroke
This trial tests whether early treatment (using a catheter to open the blocked artery) can help people with a stroke caused by a blockage in the internal carotid artery. The goal is to improve recovery and reduce disability.
Hangzhou, ZhejiangAges 18 years+ - NCT07017673RecruitingPhase 2
Ivonescimab with chemo for early-stage triple negative breast cancer
This trial tests a new drug, ivonescimab, combined with standard chemotherapy before surgery for people with high-risk early-stage triple negative breast cancer. The goal is to see if adding this drug improves treatment response.
Los Angeles, CaliforniaAges 18 years+ - NCT07018661RecruitingPhase 2/Phase 3
Testing a PET/CT scan for advanced stomach cancer
This trial tests whether a special PET/CT scan (using a drug called [18F]F-FAPI) and a laparoscopy (a small camera through the belly) can better show the spread of advanced stomach or esophagus cancer before surgery. The goal is to help doctors decide the best treatment plan.
AlmeloAges 18 years+ - NCT07019233Recruiting
Can a pressure controller help with nerve pain from chemo?
This trial tests a device that applies real-time pressure to see if it can reduce numbness, tingling, or pain caused by a chemotherapy drug called albumin paclitaxel. It may help people starting this treatment for the first time.
TianjinAges 18–75 - NCT07019350Recruiting
Smart stenting for heart artery branch blockages
This trial tests a new way to treat complex blockages in heart arteries where a side branch is also narrowed. It uses a drug-coated balloon to open the side branch, aiming to improve blood flow and reduce the need for repeat procedures.
GwangjuAges 19 years+ - NCT07019662Recruiting
Comparing a new plug device for removing ECMO tubes to standard methods
This trial tests a new suture-based device (Perclose ProStyle) to close the hole where ECMO tubes were placed in the leg, compared to manual pressure or a small surgery. It may help you recover faster with less bleeding after ECMO removal.
FrankfurtAges 18 years+ - NCT07019896Recruiting
Minimal surgery for epiretinal membrane
This trial tests a minimally invasive surgery for people with an epiretinal membrane, a thin layer of scar tissue on the retina that can blur or distort vision. The goal is to see if a smaller, less invasive approach is safe and effective.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07021352Recruiting
Ear acupuncture for emotional distress in military with PTSD
This trial tests whether ear acupuncture can help active-duty service members and veterans who have emotional distress related to PTSD. You will also receive mindfulness therapy as part of the study.
Fairfield, CaliforniaAges 18–65 - NCT07021495Recruiting
Skin disease study to improve treatment choices
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
Nijmegen, GelderlandAges 18 years+ - NCT07021820Recruiting
New light-based imaging for centronuclear myopathy
This study tests a new type of imaging that uses light and sound to look at muscles in people with centronuclear myopathy. It may help doctors see muscle changes more clearly. It does not involve any treatment or medicine.
Erlangen, BavariaAges 2 years+ - NCT07021885Recruiting
Nutrition literacy and outcomes in head and neck cancer survivors and caregivers
This study looks at how nutrition literacy (understanding food and diet) affects health outcomes for head and neck cancer survivors and their caregivers. If you are a survivor who finished treatment 6 months to 4 years ago and can eat by mouth, you and your caregiver may be able to join.
Kansas City, KansasAges 18 years+ - NCT07022197RecruitingPhase 1/Phase 2
BAFF-R CAR T cells for severe nerve and immune diseases
This trial tests a new treatment using your own immune cells (called BAFF-R CAR T cells) for people with severe nerve and immune diseases that have not improved with standard medicines. These cells are designed to target and destroy certain immune cells that may be causing your illness.
Tianjin, Tianjin MunicipalityAges 18–60 - NCT07022184Recruiting
Lifestyle app for depression with GP support
This trial tests a lifestyle app to help people with depression who are under a GP's care. It looks at whether using the app alongside your usual treatment can improve your mood.
Nijmegen, GelderlandAges 18 years+ - NCT07022418RecruitingPhase 2
Formoterol for diabetic kidney disease
This trial tests if a drug called formoterol (usually used for asthma) can help protect the kidneys in people with type 2 diabetes and early-to-moderate kidney disease. It may offer a new way to slow kidney damage.
Charleston, South CarolinaAges 18–75 - NCT07022847Recruiting
Using a finger sensor to predict low blood pressure during dialysis
This trial tests if a non-invasive finger sensor (PVI) can predict when blood pressure drops during dialysis. If successful, it could help prevent dangerous low blood pressure episodes.
Wuhu, AnhuiAges 18–80
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,446 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.